Start A Thread

Rate Intersect ENT

  • Culture

  • Compensation

  • Opportunity for advancement

  • Realistic plan attainment

×

Salaries

In our drive to help people in the medical sales industry we are gathering salary data. This information will be collated, analyzed and number crunched. Medtechy’s overall goal is to help the medical sales industry make more informed decisions when changing jobs and also keep employers and recruiters honest

Take 30 seconds and let us know your current deal.*

About The Position

Compensation

* We guarantee all data collected is completely anonymous and will only be used for the benefit of future visitors.

×

Hot Ticker Articles

The Medtechy Daily: November 16, 2018

Boston Scientific Announces New Restructuring Program

The Medtechy Daily: November 15, 2018

MiMedx Whistleblower Speaks Out

AliveCor's Next App Could Save You From a Heart Attack

Alcon files initial Form 20-F registration statement with SEC for proposed spinoff

Stereotaxis Reports 4% Recurring Growth with System Revenue Down Over 50%

Abiomed's Impella Pilot Trial to Treat Heart Attack Patients Is Successful, Moves on to Pivotal Trial

Surgical Virtual Reality Company, Fundamental VR, Signs Strategic Agreement with Mayo Clinic

Patient Dies After Undertrained Surgeon Uses Intuitive Surgical's da Vinci for Mitral Valve Surgery

Intersect ENT Message Board


Arrinex

1 year ago

I think this is where DS went. Do not know anything else about them.

Intersect ENT Earnings $XENT

1 year ago

MENLO PARK, Calif.--(BUSINESS WIRE)-- Intersect ENT, Inc. (NASDAQ:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today reported financial results for the second quarter ended June 30, 2017.

Second Quarter Financial Highlights

  • Second quarter 2017 revenue was $24.0 million, a 24% increase over the second quarter 2016
  • Second quarter 2017 gross margin was 85% compared to 84% in the second quarter 2016

Second Quarter Business Highlights

  • The …

All is great

1 year ago

All the ENT companies are in disarray except Intersect. What's in the water over there?


Intersect ENT Insider Selling Part Deux

1 year ago

Face it, Lisa has more shares than she knows what to do with. Ask why they aren't a greater part of your compensation.They will laugh. You should then understand what the E team thinks of the reps. Replaceable.



Loading...